|
|||||
![]() |
|
Personal care company Edgewell Personal Care (NYSE:EPC) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 3.2% year on year to $627.2 million. Its non-GAAP profit of $0.92 per share was 7.5% below analysts’ consensus estimates.
Is now the time to buy EPC? Find out in our full research report (it’s free).
Edgewell Personal Care faced a difficult Q2, with results that disappointed both the market and analysts. Management attributed the underperformance primarily to a very weak Sun Care season in North America and Latin America, driven by adverse weather conditions. CEO Rod Little described the quarter as "challenging," noting that Sun Care performance was a significant drag. Despite these setbacks, the company saw some positive developments, including improved market share in key brands like Hawaiian Tropic, Cremo, and Schick Hydro Silk, as well as steady international growth.
Looking forward, Edgewell Personal Care’s updated guidance reflects a cautious approach amid persistent external headwinds. Management highlighted that ongoing tariff and foreign exchange pressures, combined with the need to maintain elevated brand investments in the U.S., will continue to weigh on profitability. CEO Rod Little emphasized that these investments are necessary to "strengthen our business and better position our portfolio in the competitive U.S. market," even though they impact near-term margins. The leadership team also signaled additional transformation efforts are underway to drive long-term growth, particularly in North America.
Management pointed to the weak Sun Care season and ongoing external cost pressures as key reasons for missing expectations, while also emphasizing incremental brand investments and international execution.
Edgewell’s outlook is shaped by continued investment in brand building, ongoing external cost challenges, and a renewed focus on international growth.
Looking ahead, our analysts will focus on (1) the effectiveness of new U.S. brand campaigns and commercial leadership in driving market share gains, (2) the company’s ability to mitigate ongoing tariff and foreign exchange cost pressures through supply chain actions and pricing, and (3) sustained international sales momentum, particularly in Shave and Grooming. Progress on cash flow recovery and inventory normalization will also be important markers.
Edgewell Personal Care currently trades at $22.52, down from $25.01 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Oct-20 | |
Sep-23 | |
Sep-18 | |
Sep-05 | |
Sep-05 | |
Aug-25 | |
Aug-22 | |
Aug-15 | |
Aug-14 | |
Aug-12 | |
Aug-12 | |
Aug-12 | |
Aug-12 | |
Aug-08 | |
Aug-07 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite